Demandas del mercado de diagnóstico del cáncer y crecimiento de la industria hasta 2029</font></font>

Price: 3499 USD
Availability: InStock
Rating: 4.5 (97 reviews)
Author: Exactitude Consultancy
ISBN: 10927

Descripción general del mercado de diagnóstico del cáncer

El tamaño del mercado de diagnóstico de cáncer se valoró en USD 16,87 mil millones en 2020 y se proyecta que alcance los USD 44,22 mil millones para 2029, creciendo a una CAGR del 11,3% entre 2022 y 2029.

Los métodos actuales de diagnóstico y tratamiento del cáncer presentan graves defectos. Desde hace una década, han surgido nuevas nanoplataformas que proporcionan funciones diagnósticas y terapéuticas simultáneas para el cáncer, denominadas agentes teranósticos o simplemente teranósticos, como resultado del aumento del conocimiento y el avance tecnológico en la biología del cáncer, la ciencia de los materiales y, en particular, la nanomedicina. Estos nanodispositivos innovadores pueden dirigirse a varios marcadores del cáncer y matar células cancerosas de manera sinérgica, superando la heterogeneidad del cáncer y las dificultades de resistencia adaptativa. Además, los medicamentos teranósticos contra el cáncer pueden ser dirigidos por los resultados de las imágenes de diagnóstico, lo que da como resultado un mejor tratamiento del cáncer. Los teranósticos ideales deberían tener un tamaño compacto y una química de superficie para una absorción celular eficiente, imágenes ultrasensibles de muchos marcadores específicos del tumor , una capacidad deseable de focalización del cáncer y una alta carga y liberación controlada de medicamentos contra el cáncer, en diseños particulares. En la mayoría de los diseños se requieren otros medicamentos contra el cáncer, además de la quimioterapia. Se requieren avances en la ciencia y la ingeniería de los materiales, en particular la producción de nanocompuestos, para satisfacer estas necesidades multifuncionales de los teranósticos.

Los avances en el diagnóstico y el tratamiento del cáncer han dado lugar a un gran aumento de las tasas de supervivencia, en particular entre los niños con cáncer, lo que ha dado lugar a un cambio de paradigma en la atención hacia la supervivencia a largo plazo y las cuestiones relacionadas con la calidad de vida. Si bien las funciones cardíaca, pulmonar, renal y hepática se evalúan de forma rutinaria antes, durante y después del tratamiento, no se hace lo mismo con el sistema reproductivo. A medida que más niñas y mujeres sobreviven al cáncer, es más importante que nunca predecir los efectos del cáncer y su tratamiento en el ovario y ofrecer opciones para proteger la función reproductiva y sexual de esta población en el futuro.

ATRIBUTO	DETALLES
Periodo de estudio	2020-2029
Año base	2021
Año estimado	2022
Año pronosticado	2022-2029
Periodo histórico	2018-2020
Unit	Value (USD Billion)
Segmentation	By Product, By Application, By End Use, Region
By Product	Consumables Instruments
By Application	Breast Cancer Lung Cancer Blood Cancer Colorectal Cancer Skin Cancer Ovarian Cancer Prostate Cancer Kidney Cancer Liver Cancer Pancreatic Cancer Cervical Cancer
By End Use	Hospitals & Clinics Diagnostic Laboratories Diagnostic Centers Research Institutes
By Region	North America Asia Pacific Europe Latin America Middle East & Africa

The cancer diagnostics market would grow due to an increase in the incidence and prevalence of various types of cancer, such as breast cancer and lung cancer, over the forecast period. Furthermore, during the projection period, the cancer diagnostics sector will benefit from a surge in technical breakthroughs that aid in improved imaging of cancerous cells, improvements in equipment to detect the kind of cancer, and an increase in the efficiency of the results. Increased government activities and other private organisations aimed at raising awareness about early cancer detection and prevention are expected to drive market expansion in the future years. Furthermore, in the coming years, the market is likely to be driven by an increase in the number of diagnostics laboratories in developed countries. During the forecast period, a sharp increase in emphasis on health and safety laws, as well as a surge in popularity of yoga and other health-related practises, will provide a growth opportunity.

Government rules, a nationwide lockdown, and a spike in infection rates across countries all had a significant financial impact on neurology hospitals and clinics. Several hospitals and clinics have seen a decrease in patient visits as a result of COVID-19, resulting in reduced client engagement. Furthermore, the COVID-19 situation has caused numerous cancer tests to be delayed. There is a scarcity of medical care for disorders other than COVID-19 around the world, which has had a negative impact on the cancer diagnostics business. At the same time, limited healthcare staff availability around the world is another aspect that has a negative impact on the cancer diagnostics market.

Increased understanding of certain cancer biomarkers is creating a huge commercial opportunity for treating cancer patients through improving detection. The identification of prospective cancer biomarkers has been made possible by technological advances in the field of biotechnology, and some of these biomarkers have been marketed.

Sin embargo, el aumento de las inversiones de capital y la baja relación costo-beneficio de los biomarcadores, la creciente escasez de helio y el creciente riesgo de exposición a altas radiaciones que probablemente limiten el uso de los escáneres de TC se encuentran entre los principales factores que obstruyen el crecimiento del mercado, mientras que las directrices regulatorias cada vez más estrictas y la creciente adopción de sistemas de diagnóstico por imágenes renovados desafiarán aún más el crecimiento del mercado en el período de pronóstico. Debido al aumento de los costos, las menores tasas de reembolso y las limitaciones presupuestarias, muchos hospitales en las naciones más pobres no pueden invertir en tecnología de diagnóstico por imágenes. Sin embargo, debido a la creciente demanda de operaciones de diagnóstico por imágenes en estos países, los hospitales que no pueden permitirse comprar nuevos equipos de diagnóstico por imágenes optan por utilizar sistemas de segunda mano. Los sistemas renovados son menos costosos que los sistemas nuevos, ya que cuestan entre el 40% y el 60% del precio de compra original.

[título id="attachment_10932" align="aligncenter" width="870"]

Cancer Diagnostics Market | Exactitude Consultancy

Mercado de diagnóstico del cáncer | Exactitude Consultancy[/subtítulo]

Frequently Asked Questions

• What is the worth of global cancer diagnostics market?

The cancer diagnostics market size was valued at USD 16.87 billion in 2020 and is projected to reach USD 44.22 billion by 2029, growing at a CAGR of 11.3% from 2022 to 2029 due to an increase in the incidence and prevalence of various types of cancer.

• What is the size of the North America cancer diagnostics industry?

North America held more than 40% of the cancer diagnostics market revenue share in 2021. Technological breakthroughs in diagnostic tests, rising healthcare spending, and more patient knowledge about early cancer diagnosis are some of the major reasons driving diagnostics adoption in the region.

• What are the upcoming trends of cancer diagnostics market, globally?

Cancer research organizations, as well as public and commercial entities, are substantially investing in research initiatives in order to bring better diagnostic tools to market that can diagnose the disease long before symptoms occur.

• What is the CAGR of cancer diagnostics market?

The global cancer diagnostics market registered a CAGR of 11.3% from 2022 to 2029. The consumables segment is the major revenue contributor in the market.

• Which are the top companies to hold the market share in cancer diagnostics market?

Key players profiled in the report include Abbott, Agilent Technologies, Inc., BD, bioMérieux SA, NeoGenomics Laboratories, Inc., Telerad Tech, F. Hoffmann-La Roche Ltd and others are dominating the market share.

• What is the leading application of cancer diagnostics market?

The breast cancer segment is the largest application in the cancer diagnostics market.

• Which is the largest regional market for cancer diagnostics market?

North America is the largest market for cancer diagnostics market.

Cancer Diagnostics Market Segment Analysis

On the basis of product, the consumables segment is the major revenue contributor, and is projected to grow significantly during the forecast period. Increased adoption of consumables for cancer diagnostics, an increase in cancer prevalence, an increase in R&D investment, an increase in the geriatric population, the introduction of technologically advanced products, and an increase in the launch of new & advanced kits and reagents are all driving the segment's growth.

Due to the rise in breast cancer occurrence around the world and an increase in the population of women aged 50 to 74, the breast cancer segment is the largest stakeholder in the cancer diagnostics market, depending on application. In the next years, an increase in the number of efforts conducted by various groups will help the industry gain traction.

The hospitals & clinics segment, based on end use, is the largest shareholder in the cancer diagnostics market, owing to an increase in the number of patients visiting hospitals, an increase in the number of in-house diagnostic procedures performed in hospitals, and an increase in awareness about early diagnosis, all of which are major driving factors for this market.

[caption id="attachment_10937" align="alignleft" width="680"]

Cancer Diagnostics Market | Exactitude Consultancy[/caption]

Cancer Diagnostics Market Players

The major players covered in the cancer diagnostics market report are Abbott, Agilent Technologies, Inc., BD, BioMérieux SA, NeoGenomics Laboratories, Inc., Telerad Tech, F. Hoffmann-La Roche Ltd, GENERAL ELECTRIC COMPANY, Hologic Inc., Illumina, Inc., QIAGEN, BioGenex, Siemens Healthcare GmbH, BioNTech Diagnostics GmbH, Thermo Fisher Scientific Inc. and Koninklijke Philips N.V. among other domestic and global players.

Abbott is a globally diversified healthcare company with a central purpose to help people live their healthiest possible lives. We offer a broad portfolio of market-leading products that align with favourable long-term healthcare trends in both developed and developing markets.
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California. Agilent was established in 1999 as a spin-off from Hewlett-Packard.
NeoGenomics is a premier cancer diagnostic, pharma services, and information services company serving oncologists, pathologists, pharmaceutical companies, and academic centres in their pursuit of providing better futures for people living with cancer.

Who Should Buy? Or Key Stakeholders

Healthcare Industry
Hospitals and Clinics
Medical Laboratories
Pharmaceutical Industry
Scientific Research and Development
Investors
Manufacturing companies
End user companies
Others

Cancer Diagnostics Market Regional Analysis

The global cancer diagnostics market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

North America is predicted to play a significant role in the growth of the cancer diagnostics industry. The emergence of COVID-19 had a negative impact on the market examined in the region. According to the Union for International Cancer Controls (UICC), cancer diagnosis rates in the United States dropped significantly during the epidemic. According to the survey's findings, the number of newly diagnosed metastatic non-small cell lung cancer patients decreased by just over 30% from February to March 2020. Colorectal cancer (14 percent), acute myeloid leukaemia (14 percent), breast cancer (8.4%), and ovarian cancer (14 percent) also saw declines (8.6 percent). Such occurrences point to a decrease in cancer diagnosis rates during the pandemic era.

[caption id="attachment_10938" align="alignnone" width="680"]

Cancer Diagnostics Market | Exactitude Consultancy[/caption]

Key Market Segments: Cancer Diagnostics Market

Cancer Diagnostics Market By Product, 2020-2029, (USD Million)

Consumables
Instruments

Cancer Diagnostics Market By Application, 2020-2029, (USD Million)

Breast Cancer
Lung Cancer
Blood Cancer
Colorectal Cancer
Skin Cancer
Ovarian Cancer
Prostate Cancer
Kidney Cancer
Liver Cancer
Pancreatic Cancer
Cervical Cancer

Cancer Diagnostics Market By End Use, 2020-2029, (USD Million)

Hospitals & Clinics
Diagnostic Laboratories
Diagnostic Centres
Research Institutes

Cancer Diagnostics Market By Region, 2020-2029, (USD Million)

North America
Europe
Asia Pacific
South America
Middle East and Africa

Important Countries In All Regions Are Covered.

Key Question Answered

What are the growth opportunities related to the adoption of cancer diagnostics across major regions in the future?
What are the new trends and advancements in the cancer diagnostics market?

Which product categories are expected to have highest growth rate in the cancer diagnostics market?

Which are the key factors driving the cancer diagnostics market?
What will the market growth rate, growth momentum or acceleration the market carries during the forecast period?

Introducción
1. Definición de mercado
2. Segmentación del mercado
3. Cronología de la investigación
4. Supuestos y limitaciones

Metodología de la investigación
1. Minería de datos
  1. Investigación secundaria
  2. Investigación primaria
  3. Asesoramiento de expertos en la materia
2. Controles de calidad
  1. Revisión final
3. Triangulación de datos
  1. Enfoque de abajo hacia arriba
  2. Enfoque de arriba hacia abajo
  3. Flujo de investigación
4. Fuentes de datos

Resumen ejecutivo

Descripción general del mercado
1. Perspectivas del mercado mundial de diagnóstico del cáncer
  1. Factores impulsores del mercado
  2. Restricciones del mercado
  3. Oportunidades de mercado
2. Impacto de la COVID-19 en el mercado mundial de diagnóstico del cáncer

Mercado mundial de diagnóstico del cáncer por producto (millones de USD)
1. Consumibles
2. Instrumentos

Mercado mundial de diagnóstico del cáncer por aplicación (millones de USD)
1. Cáncer de mama
2. Cáncer de pulmón
3. Cáncer de sangre
4. Cáncer colorrectal
5. Cáncer de piel
6. Cáncer de ovario
7. Cáncer de próstata
8. Cáncer de riñón
9. Cáncer de hígado
10. Cáncer de páncreas
11. Cáncer de cuello uterino

Mercado mundial de diagnóstico del cáncer por uso final (millones de USD)
1. Hospitales y clínicas
2. Laboratorios de diagnóstico
3. Centros de diagnóstico
4. Institutos de investigación

Mercado mundial de diagnóstico del cáncer por región (millones de USD)
1. Introducción
2. Asia-Pacífico
  1. Porcelana
  2. India
  3. Japón
  4. Corea del Sur
  5. Australia
  6. Sudeste asiático
  7. Resto de Asia-Pacífico
3. América del norte
  1. Estados Unidos
  2. Canadá
  3. México
4. Europa
  1. Alemania
  2. Reino Unido
  3. Francia
  4. Italia
  5. España
  6. Rusia
  7. Resto de Europa
5. Sudamerica
  1. Brasil
  2. Argentina
  3. Colombia
  4. Resto de Sudamérica
6. Oriente Medio y África
  1. Emiratos Árabes Unidos
  2. Arabia Saudita
  3. Sudáfrica
  4. Resto de Oriente Medio y África

Perfiles de empresas* (descripción general de la empresa, descripción general de la empresa, aplicaciones ofrecidas, desarrollos recientes)
1. 1. Abad
  2. Tecnologías Agilent, Inc.
  3. BD
  4. BioMérieux SA
  5. Laboratorios NeoGenomics, Inc.
  6. Tecnología Telerad
  7. Hoffmann-La Roche Ltd
  8. Compañía hologica inc.
  9. Ilumina, Inc.
  10. QIAGEN
  11. BioGenex
  12. Siemens Healthcare GmbH
  13. BioNTech Diagnostics GmbH
  14. Otros *El listado de empresas es orientativo

LISTA DE TABLAS

TABLE 1          GLOBAL CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 2          GLOBAL CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 3          GLOBAL CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 4          GLOBAL CANCER DIAGNOSTICS MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 5          US CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 6          US CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 7          US CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 8          CANADA CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 9          CANADA CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 10       CANADA CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 11       MEXICO CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 12       MEXICO CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 13       MEXICO CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 14       BRAZIL CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 15       BRAZIL CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 16       BRAZIL CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 17       ARGENTINA CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 18       ARGENTINA CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 19       ARGENTINA CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 20       COLOMBIA CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 21       COLOMBIA CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 22       COLOMBIA CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 23       REST OF SOUTH AMERICA CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 24       REST OF SOUTH AMERICA CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 25       REST OF SOUTH AMERICA CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 26       INDIA CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 27       INDIA CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 28       INDIA CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 29       CHINA CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 30       CHINA CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 31       CHINA CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 32       JAPAN CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 33       JAPAN CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 34       JAPAN CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 35       SOUTH KOREA CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 36       SOUTH KOREA CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 37       SOUTH KOREA CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 38       AUSTRALIA CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 39       AUSTRALIA CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 40       AUSTRALIA CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 41       SOUTH-EAST ASIA CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 42       SOUTH-EAST ASIA CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 43       SOUTH-EAST ASIA CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 44       REST OF ASIA PACIFIC CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 45       REST OF ASIA PACIFIC CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 46       REST OF ASIA PACIFIC CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 47       GERMANY CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 48       GERMANY CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 49       GERMANY CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 50       UK CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 51       UK CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 52       UK CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 53       FRANCE CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 54       FRANCE CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 55       FRANCE CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 56       ITALY CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 57       ITALY CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 58       ITALY CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 59       SPAIN CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 60       SPAIN CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 61       SPAIN CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 62       RUSSIA CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 63       RUSSIA CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 64       RUSSIA CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 65       REST OF EUROPE CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 66       REST OF EUROPE CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 67       REST OF EUROPE CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 68       UAE CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 69       UAE CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 70       UAE CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 71       SAUDI ARABIA CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 72       SAUDI ARABIA CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 73       SAUDI ARABIA CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 74       SOUTH AFRICA CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 75       SOUTH AFRICA CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 76       SOUTH AFRICA CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

TABLE 77       REST OF MIDDLE EAST AND AFRICA CANCER DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 78       REST OF MIDDLE EAST AND AFRICA CANCER DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 79       REST OF MIDDLE EAST AND AFRICA CANCER DIAGNOSTICS MARKET BY END USE (USD MILLIONS) 2020-2029

LIST OF FIGURES

FIGURE 1       MARKET DYNAMICS

FIGURE 2       MARKET SEGMENTATION

FIGURE 3       REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4       DATA TRIANGULATION

FIGURE 5       BOTTOM-UP APPROACH

FIGURE 6       TOP-DOWN APPROACH

FIGURE 7       RESEARCH FLOW

FIGURE 8       GLOBAL CANCER DIAGNOSTICS MARKETBY PRODUCT, USD MILLION, 2020-2029

FIGURE 10     GLOBAL CANCER DIAGNOSTICS MARKETBY APPLICATION, USD MILLION, 2020-2029

FIGURE 11     GLOBAL CANCER DIAGNOSTICS MARKETBY END USE, USD MILLION, 2020-2029

FIGURE 12     GLOBAL CANCER DIAGNOSTICS MARKETBY REGION, USD MILLION, 2020-2029

FIGURE 13     PORTER’S FIVE FORCES MODEL

FIGURE 14     GLOBAL CANCER DIAGNOSTICS MARKETBY PRODUCT, 2020

FIGURE 15     GLOBAL CANCER DIAGNOSTICS MARKETBY APPLICATION 2020

FIGURE 16     GLOBAL CANCER DIAGNOSTICS MARKETBY END USE 2020

FIGURE 17     CANCER DIAGNOSTICS MARKETBY REGION 2020

FIGURE 18     MARKET SHARE ANALYSIS

FIGURE 19     ABBOTT: COMPANY SNAPSHOT

FIGURE 20     AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT

FIGURE 21     BD: COMPANY SNAPSHOT

FIGURE 22     BIOMÉRIEUX SA: COMPANY SNAPSHOT

FIGURE 23     NEOGENOMICS LABORATORIES, INC.: COMPANY SNAPSHOT

FIGURE 24     TELERAD TECH: COMPANY SNAPSHOT

FIGURE 25     F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT

FIGURE 26     HOLOGIC INC.: COMPANY SNAPSHOT

FIGURE 27     ILLUMINA, INC.: COMPANY SNAPSHOT

FIGURE 28     QIAGEN: COMPANY SNAPSHOT

FIGURE 29     BIOGENEX: COMPANY SNAPSHOT

Identifying Key Products in the Market

The identification of key products in any market is pivotal for understanding what drives consumer interest, technological innovation, and competitive advantage. Here’s how to approach this:
Market Analysis Reports: Start with syndicated market analysis reports from firms like Nielsen, Euromonitor, or specialized industry analysts. These reports often highlight leading products based on sales data, innovation, and consumer feedback.
Patent Filings: Reviewing patent filings can provide insight into technological innovations and future products that may impact the market. Databases like the United States Patent and Trademark Office (USPTO) or the World Intellectual Property Organization (WIPO) can be invaluable.
Ecommerce Platforms and Retailer Websites: Analyzing bestselling products and customer reviews on platforms such as Amazon, Flipkart, or direct retailer websites can offer direct insights into consumer preferences and product popularity.
Consumer Surveys and Feedback: Conducting surveys or analyzing online forums and social media can reveal consumer preferences, pain points, and desired features in products. Tools like SurveyMonkey, Google Surveys, or social listening platforms can facilitate this process.

Segmenting the Market and Products

Market and product segmentation is crucial for targeting marketing efforts and product development. Here’s a methodology for segmenting based on technical specifications:
Technical Specifications Review: Compile a comprehensive list of products within the market, focusing on their technical specifications. This could involve processor speeds for electronics, ingredients for food products, or material composition for apparel.
Factor Analysis: Use statistical techniques like factor analysis to group products based on shared technical specifications. This method helps identify underlying relationships between different specifications and how they cluster together.
Expert Consultation: Engage with industry experts or technical specialists to ensure that the segmentation makes sense from both a market and a technical perspective. This step ensures the practical relevance of the segments identified.

Identifying and Classifying Key Application Segments

Understanding how products are used in different applications is essential for market strategy:
Use Case Analysis: Identify common use cases for products by reviewing product literature, customer testimonials, and case studies. This helps understand the variety of applications each product serves.
Industry Surveys: Conduct surveys targeting professionals in the field to understand how and why certain products are preferred in specific applications. This can also reveal unmet needs in the market.
ApplicationBased Segmentation: Group products based on their primary applications, considering factors such as industry use, consumer vs. professional use, and environmental conditions.

Calculating Market Size Using TopDown and BottomUp Approaches

Estimating the market size accurately is fundamental for strategic planning:
TopDown Approach: Start with global industry data and narrow down to the target market by applying known market shares or segmentation percentages. Industry reports and financial databases are key sources for this approach.
BottomUp Approach: Aggregate sales data or unit shipments from all known market participants. This might require gathering data from company reports, industry associations, and sales channels.
Combining Approaches: Validate the market size estimates by comparing the results from both approaches. Discrepancies can highlight areas requiring further investigation.

Calculating the CAGR for the Market

The Compound Annual Growth Rate (CAGR) is a useful measure to understand market growth over time:
Historical Sales Data: Gather historical sales or market size data over a defined period. Public company filings, industry reports, and government databases can be sources for this data.
CAGR Formula: Apply the CAGR formula \[CAGR = (EV/BV)^{1/n} 1\], where EV is the end value, BV is the beginning value, and n is the number of periods.
Segment and Overall Market CAGR: Calculate CAGR for both the overall market and individual segments to understand growth patterns.

Sources for Secondary or Desk Research

Identifying the right sources is crucial for accurate desk research:
Industry and Market Research Reports: Sources like IBISWorld, Statista, and Frost & Sullivan offer comprehensive industry reports.
Government and International Organizations: Websites of the U.S. Census Bureau, World Bank, and OECD provide economic and industry specific data.
Academic Journals: Platforms like Google Scholar and JSTOR can offer peer reviewed articles on market trends and consumer behavior.
News Archives and Trade Publications: Stay informed on industry developments through sources like Bloomberg, Reuters, and specific trade journals relevant to the market in question.
Each of these steps requires careful consideration and a systematic approach to ensure that the market research report is robust, insightful, and actionable.

Cancer Diagnostics Market

Base Year Value ()

CAGR ()

Forecast Year Value ()

Historical Data Period

Largest Region

Forecast Period

Instant access to hundreds of data points and trends

Descripción general del mercado de diagnóstico del cáncer

Frequently Asked Questions

• What is the worth of global cancer diagnostics market?

• What is the size of the North America cancer diagnostics industry?

• What are the upcoming trends of cancer diagnostics market, globally?

• What is the CAGR of cancer diagnostics market?

• Which are the top companies to hold the market share in cancer diagnostics market?

• What is the leading application of cancer diagnostics market?

• Which is the largest regional market for cancer diagnostics market?

Cancer Diagnostics Market Segment Analysis

Cancer Diagnostics Market Players

Who Should Buy? Or Key Stakeholders

Cancer Diagnostics Market Regional Analysis

Key Market Segments: Cancer Diagnostics Market

Key Question Answered

LISTA DE TABLAS

LIST OF FIGURES

DOWNLOAD FREE SAMPLE REPORT

License Type

Get Sample to Email

SPEAK WITH OUR ANALYST

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

Talk to Expert

+1 (704) 266-3234

Send an Email

Contact us

Quick Links

We accept